Your daily news update from the Belfast News Letter
View email online | | | | | May 26, 2020 | | | | | | Hello there, We hope you had as nice a bank holiday as possible on Monday. We have some positive news for you today - Health Minister, Robin Swann, that the anti-viral drug Remdesivir will be available in Northern Ireland for the treatment of Covid-19. Remdesivir is an innovative drug that is currently undergoing clinical trials around the world, including the UK. International studies show the drug can shorten recovery time from Covid-19 by about four days. We also have a report on how the PSNI is to investigate yet another republican funeral where people allegedly broke Coronavirus social distancing measures. In keeping with the theme of Coronavirus, we have the latest on a Derry City footballer who has tested positive for COVID-19. I hope you have a great day, Alistair Bushe Editor, News Letter Twitter: @abushe7
If you receive this email as a subscriber thank you for supporting us. If you are a registered reader on our site you can further help us continue to produce quality journalism that matters. Digital subscriptions to the News Letter are available on www.newsletter.co.uk/subscriptions and pay just £1 for the first three months Lockdown survey: With planning going on to ease the lockdown how do you feel about restrictions being relaxed? We are inviting you to take part in this quick survey. https://www.surveymonkey.co.uk/r/lockdownsnap-NI | |
| | | | | | |
|
| | | | | | | | | | | You have received this email as you are opted in to newsletters from the News Letter, published by JPIMedia Publishing Ltd. To manage your individual newsletter preferences with us, please click here and log in to your account. | | | Alternatively you can update your email preferences to choose the types of emails you receive from JPIMedia Publishing Ltd, or unsubscribe from all future emails. | | | JPIMedia Publishing Ltd, a company registered in England and Wales with registered number 11499982, having its registered address at Third Floor, 1 King William Street, London, England, EC4N 7AF, United Kingdom. We will process your personal data in accordance with our privacy policy. | |
|